You are subscribed to Drug Shortages for U.S. Food & Drug Administration (FDA). This information has recently been updated.
February 5, 2015
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
-
Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection (Updated - Currently in Shortage)
-
Cefazolin Injection (Updated - Currently in Shortage)
-
Dextrose 5% Injection Bags (Updated - Currently in Shortage)
-
Dextrose Injection USP, 70% (Updated - Currently in Shortage)
-
Epinephrine Injection (Updated - Currently in Shortage)
-
Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
-
Irrigation Solutions (Updated - Currently in Shortage)
-
Ketorolac Tromethamine Injection (New - Currently in Shortage)
-
Lidocaine Hydrochloride (Xylocaine) Injection (Updated - Currently in Shortage)
-
Magnesium Sulfate Injection (Updated - Currently in Shortage)
-
Memantine Hydrochloride (Namenda) XR Capsules (Updated - Currently in Shortage)
-
Nitroglycerin in 5% Dextrose Injection (Updated - Resolved)
-
Nitroglycerin in 5% Dextrose Injection (Updated - Discontinuation)
-
Phenylephrine (Mydfrin) Ophthalmic Solution (New - Currently in Shortage)
-
Potassium Chloride Injection (Updated - Currently in Shortage)
| This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
